Search

After seven years, multi-center clinical trial finds systemic therapy better preserves visual acuity and has fewer side effects Boston, Mass. — Systemic therapy consisting of corticosteroids and immunosuppressants preserved vision of uveitis patients better – and had fewer adverse outcomes – than a...

Eli Peli, MSc, OD, has joined the board for directors of ITN America. This non-profit provides ride services for the elderly and visually impaired. They support sustainable, community-based transportation services for seniors throughout the world by building a senior transportation network through...

Prestigious award honors outstanding research in ophthalmology Boston, Mass. — The Association for Research in Vision and Ophthalmology (ARVO) recently announced that Reza Dana, MD, MPH, MSc, Director of Cornea and Refractive Surgery at Massachusetts Eye and Ear and a resident of Newton, Mass., will...

Research Grant Awarded to Dr. Brian J. Song, Massachusetts Eye and Ear Infirmary, and Department of Ophthalmology at Harvard Medical School CHICAGO (June 5, 2017) – Prevent Blindness , the nation’s oldest volunteer eye health and safety organization, announced today the recipient of its 2017 Joanne...

In February 2016, Reza Dana, MD, MPH, MSc, Vice Chair for Academic Programs for the Harvard Medical School (HMS) Department of Ophthalmology, and Director of the Cornea and Refractive Surgery Service at Massachusetts Eye and Ear, was elected to Academia Ophthalmologica Internationalis (AOI), one of...

Another one for the books, congratulations to Dr. Matyal and team for publishing a review article about neuropeptide Y in the European Journal of Pharmacology earlier this year!

Findings could eventually lead to first non-surgical therapies and treatments for FECD. BOSTON -- Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs’ Endothelial...

Congratulations to the Valve Research Group for their wonderful posters and presentations at the 38th Annual SCA Conference! Of note were the five out of fifteen 'Best of Meeting Abstract Presentations' that were authored and presented by our very own Ziyad Knio, Jelliffe Jeganathan and Rabya Saraf.

A complication associated with bone marrow transplantation, graft-versus-host-disease occurs when a transplanted immune system attacks certain parts of a host’s body, and may cause severe dry eye and damage to the cornea. A clinical trial at Massachusetts Eye and Ear showed that topical doses of...

Selecta is licensing Anc80 from Massachusetts Eye and Ear for a rare genetic disease with options on additional pre-specified indications. By combining Anc80 with Selecta’s investigational drug candidate, SVP-Rapamycin (SEL-110), Selecta is seeking to advance a new gene therapy platform designed to...